imatinib mesylate has been researched along with Capillary Leak Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinchcliff, ME; Johnson, JA; Lomasney, J; Varga, J | 1 |
1 review(s) available for imatinib mesylate and Capillary Leak Syndrome
| Article | Year |
|---|---|
Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate.
Topics: Antineoplastic Agents; Biopsy; Capillary Leak Syndrome; Fatal Outcome; Female; Humans; Imatinib Mesylate; Middle Aged; Scleroderma, Systemic | 2016 |